| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 10/18/1989 | EP0336956A1 Defective recombinant gene which can be activated by a transactivator |
| 10/12/1989 | DE3828842A1 Process for the treatment of RNA and/or DNA |
| 10/11/1989 | EP0336822A1 Defective recombinant retrovirus,its use for integrating protein coding sequences in the genome of cell culture which can be infected by corresponding wild-type retrovirus,and recombinant DNA for obtaining this recombinant retrovirus |
| 10/05/1989 | WO1989009271A1 Recombinant retroviruses |
| 10/04/1989 | EP0335635A1 Mutated HIV envelope protein |
| 09/27/1989 | EP0334679A2 Improvements in or relating to the inactivation of infectious agents |
| 09/27/1989 | EP0334530A1 A recombinant marek's disease virus and a vaccine |
| 09/27/1989 | EP0334301A1 Recombinant retroviruses |
| 09/26/1989 | US4870023 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
| 09/26/1989 | CA1261773A1 Non-a, non-b hepatitis assay and vaccine |
| 09/26/1989 | CA1261772A1 Equine influenza virus and its cultivation |
| 09/26/1989 | CA1260392A1 Hepatitis a virus purified and triply cloned |
| 09/21/1989 | WO1989008716A1 Novel recombinant vaccinia virus expression vectors and method of selecting same |
| 09/21/1989 | WO1989008701A1 Process and device for producing viruses and viral antigens |
| 09/21/1989 | DE3833925A1 Verfahren und herstellung von virus und viralem antigen und vorrichtung hierzu Process and production of virus and viral antigen and device for this purpose |
| 09/20/1989 | EP0332677A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 09/13/1989 | EP0332241A2 Live combination vaccine |
| 09/12/1989 | US4865979 Novel bacteriophage and method for breeding thereof |
| 09/08/1989 | WO1989008145A1 Non-nuclear chromosomal transformation |
| 09/06/1989 | EP0330781A1 Vaccine against rinderpest virus using recombinant vaccinia virus |
| 08/30/1989 | EP0330051A1 Human cytomegalovirus structural phosphoprotein (pp28), its preparation and use |
| 08/29/1989 | US4861720 Oncornavirus vaccines and feline alpha-type interferon |
| 08/22/1989 | US4859769 Antiviral agents |
| 08/22/1989 | US4859597 Streptococcal lysin |
| 08/22/1989 | US4859587 Recombinant herpes simplex viruses, vaccines and methods |
| 08/16/1989 | EP0328123A1 Heterogeneous, pre-S rich hepatitis B surface antigen |
| 08/16/1989 | EP0327626A1 Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors |
| 08/16/1989 | CN1034757A Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors |
| 08/15/1989 | US4857514 Virus inactivation |
| 08/10/1989 | WO1989006972A1 Preparation of a recombinant subunit vaccine against pseudorabies infection |
| 08/09/1989 | EP0327305A2 Preparation of a recombinant subunit vaccine against pseudorabies infection |
| 08/08/1989 | US4855090 Method of producing high aqueous volume multilamellar vesicles |
| 08/02/1989 | EP0325768A2 Non-reverting rna viruses |
| 08/02/1989 | EP0325635A1 Production of hblv virus in the hsb-2 cell line |
| 07/27/1989 | WO1989006542A1 Preservation of viruses |
| 07/26/1989 | EP0324811A1 Gas inlet for a plurality of various reaction gases in reaction vessels |
| 07/19/1989 | EP0324350A1 Recombinant vaccinia virus MVA |
| 07/19/1989 | EP0324018A1 Production of lysin-free phage inoculum and production of lysin |
| 07/18/1989 | CA1257543A1 Assaying biological samples for antibody to retroviruses |
| 07/13/1989 | WO1989006280A1 Multiple stage affinity process for isolation of specific cells from a cell mixture |
| 07/13/1989 | WO1989006277A1 Attenuated viruses |
| 07/12/1989 | EP0323900A1 Attenuated viruses |
| 07/12/1989 | EP0323829A2 Multiple stage affinity process for isolation of specific cells from a cell mixture |
| 07/12/1989 | EP0323708A1 Rotavirus reassortant vaccine |
| 07/12/1989 | EP0323480A1 Genetically engineered vaccines for mycobacteria |
| 07/05/1989 | EP0322417A1 Empty viral capsid vaccines |
| 06/29/1989 | WO1989005823A1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 06/29/1989 | WO1989005658A1 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis |
| 06/29/1989 | DE3743094A1 Retrovirus from the HIV group, method for its replication/isolation and its use |
| 06/20/1989 | US4840896 Human fertility hormones rna encoding by vectors |
| 06/15/1989 | WO1989005353A1 Common acute lymphoblastic leukemia antigen |
| 06/15/1989 | WO1989005154A1 Process for producing an avirulent cold blood virus |
| 06/14/1989 | EP0320495A1 Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof |
| 06/14/1989 | EP0319815A2 Transfectant cell lines which express the major human rhinovirus receptor |
| 06/13/1989 | US4839288 Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
| 06/07/1989 | EP0319418A1 Densonucleosis provoking plasmids, methods for obtaining them and their use in combating ravaging insects |
| 06/01/1989 | WO1989004869A1 Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process |
| 05/31/1989 | EP0317804A2 HIV peptides and methods for detection of HIV |
| 05/23/1989 | US4833165 Method of inactivating HTLV-III virus in blood |
| 05/18/1989 | WO1989004170A1 Microencapsulated insecticidal pathogens |
| 05/10/1989 | EP0315459A2 HIV incomplete particles and a method for production thereof |
| 05/05/1989 | WO1989003882A1 Multiple promoter transforming retroviral vectors |
| 05/05/1989 | WO1989003879A1 Fowlpox virus promoters |
| 05/05/1989 | WO1989003878A1 Defective recombinant gene which can be activated by a transactivator |
| 05/03/1989 | EP0314569A1 Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus |
| 04/26/1989 | EP0312839A2 Method for the preparation of an inducer of non-specific immunity |
| 04/25/1989 | US4824668 Attenuated infectious bursal disease virus strain and vaccine therefrom |
| 04/25/1989 | US4824667 Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same |
| 04/25/1989 | CA1253093A1 Rabies vaccine and preparation process thereof |
| 04/20/1989 | WO1989003429A1 Recombinant avipox virus |
| 04/20/1989 | WO1989002469A3 Human erythroid-specific transcriptional enhancer |
| 04/12/1989 | EP0311228A2 Recombinant polypeptides and their uses, including assay for AIDS virus |
| 04/06/1989 | WO1989002935A1 Respiratory syncytial virus: vaccines and diagnostic assays |
| 04/05/1989 | EP0310362A2 Vaccine for protection of cats against feline infectious peritonitis |
| 04/05/1989 | EP0310317A2 Inactivation of viruses and bacteria |
| 04/05/1989 | EP0310316A2 TGEV-virus of swine as a dog vaccine |
| 03/29/1989 | EP0308883A2 Process for cloning DNA sequences or for the production of gene libraries, cloning vectors, and micro-organism strains containing them |
| 03/23/1989 | WO1989002469A2 Human erythroid-specific transcriptional enhancer |
| 03/21/1989 | US4814277 Method of inactivating reproductive filterable pathogens |
| 03/21/1989 | US4814268 Methods for propagating fastidious human viruses and for producing purified suspensions thereof |
| 03/21/1989 | CA1251401A1 Method for preparation of herpes simplex virus subunit vaccine |
| 03/21/1989 | CA1251400A1 Method for purification of japanese encephalitis virus |
| 03/21/1989 | CA1251399A1 Method for purification of influenza virus |
| 03/21/1989 | CA1251398A1 Method for purification of rabic virus |
| 03/21/1989 | CA1251397A1 Live purified marek's disease vaccine |
| 03/09/1989 | WO1989001940A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 03/08/1989 | EP0306219A2 Novel HIV proteins and peptides useful in the diagnosis, prophylaxis or therapy of AIDS |
| 03/08/1989 | EP0305777A2 Synthesis of human immunodeficiency virus type 1 antigens and their use as diagnostic and therapeutic agents |
| 03/07/1989 | US4810634 Pseudorabies virus mutants incapable of producing glycoprotein X |
| 03/07/1989 | US4810494 Canine parvovirus vaccines |
| 03/07/1989 | US4810493 Method for the culture of the TRT/SHS virus, and vaccine therefrom, especially for the treatment of turkeys |
| 03/01/1989 | EP0305229A1 Viral vector and recombinant DNA encoding one or more structural proteins (HA,F and/or NP) of a morbillivirus |
| 03/01/1989 | EP0305087A1 Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors |
| 03/01/1989 | EP0304578A1 Peptide comprising hepatitis B surface antigen |
| 02/23/1989 | WO1989001518A1 Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors |
| 02/23/1989 | WO1989001516A1 Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus |
| 02/22/1989 | EP0304344A1 Viruses related to the hepatitis B virus, their constituents and their use as a vaccine or diagnostic reagent |
| 02/15/1989 | EP0303364A1 Cloning and nucleotide sequence determination of the isopenicillin N synthetase gene from streptomyces clavuligerus |
| 02/09/1989 | WO1989001040A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 02/09/1989 | WO1989001030A1 Production of lysin-free phage inoculum and production of lysin |